Brazil's plastic surgery demand rises as weight‑loss drugs spur rapid slimming

The growing use of injectable weight‑loss medications such as Mounjaro and Ozempic in Brazil has led to a noticeable increase in patients seeking plastic‑surgery procedures to address skin laxity and contour changes after rapid weight loss. Plastic surgeon Dr. Felipe Mendonça reports that individuals who achieve significant weight reduction with these drugs are now turning to body‑contouring and facial surgeries to remove excess skin and restore volume.

The surgical approach has evolved, with techniques like Argoplasma and Ugraft being employed to tighten skin and improve aesthetic outcomes while minimizing scarring. Studies cited in the Aesthetic Surgery Journal confirm the correlation between the popularity of weight‑loss drugs and a rise in post‑weight‑loss plastic‑surgery demand, highlighting a new patient profile in Brazil’s cosmetic‑surgery market.